Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2021-03-31, filed 2021-08-11, with 50 holding rows worth $425,474,000.

Accession
0001420506-21-001026
Filed
2021-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, amendment of type restatement, 50 entries on the cover page, a total value of $425,474,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $425,474,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVESCO QQQ TR46090E103COM150,000$47,870,000thousands by filing dateput
SYNDAX PHARMACEUTICALS INC87164F105COM1,175,000$26,273,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock1,950,000$20,943,000thousands by filing date
ARK ETF TR00214Q302GENOMIC REV ETF200,000$17,746,000thousands by filing dateput
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR135,000$17,399,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock600,000$16,962,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM500,000$15,830,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM185,000$15,253,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock850,000$15,215,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock600,000$15,120,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM325,000$14,420,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM1,600,000$14,048,000thousands by filing date
ARVINAS INC04335A105COM205,000$13,551,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM225,000$9,655,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock200,000$9,640,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM4,143,702$8,826,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM50,000$8,565,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS939,043$7,850,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM650,000$7,722,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock450,000$7,281,000thousands by filing date
IVERIC BIO INC46583P102COM1,125,000$6,953,000thousands by filing date
iShares Russell 2000 ETF464287655SHS30,000$6,628,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock275,000$6,432,000thousands by filing date
BIOGEN INC COM09062X103Stock20,000$5,595,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW250,000$5,150,000thousands by filing date
SATSUMA PHARMACEUTICALS INC80405P107COM904,225$5,136,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM500,000$5,118,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock500,000$5,085,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW175,000$5,084,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM1,000,000$5,040,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM300,000$5,013,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock500,000$4,964,000thousands by filing date
CURIS INC231269200COM425,000$4,811,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS150,000$4,481,000thousands by filing date
FIBROGEN INC31572Q808COM125,000$4,339,000thousands by filing date
IMMUNIC INC4525EP101COM265,000$4,224,000thousands by filing date
IMMUNOVANT INC45258J102COM250,000$4,010,000thousands by filing date
SIERRA ONCOLOGY INC82640U404CMN200,000$3,446,000thousands by filing date
NOVAVAX INC670002401COM NEW17,500$3,173,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM265,000$2,618,000thousands by filing date
KADMON HLDGS INC48283N106COM600,000$2,334,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM30,000$2,246,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM750,000$2,183,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM200,000$2,070,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW100,000$2,060,000thousands by filing dateput
CHIMERIX INC COM16934W106Stock200,000$1,928,000thousands by filing date
CASI PHARMACEUTICALS INC14757U109COM650,000$1,560,000thousands by filing date
APTEVO THERAPEUTICS INC03835L207COMMON50,000$1,526,000thousands by filing date
OTONOMY INC68906L105COM450,000$1,148,000thousands by filing date
FREQUENCY THERAPEUTICS INC35803L108COM100,000$950,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-000663 superseded2021-05-14acceptance time not in the bulk data set
13F-HR/A 0001420506-21-001026this filing2021-08-11acceptance time not in the bulk data set